Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury

Purinergic Signalling

Volumn 9, Issue 3, 2013, Pages 451-462

  Franke, Heike ^a   Parravicini, Chiara ^b   Lecca, Davide ^b   Zanier, Elisa R ^c   Heine, Claudia ^a   Bremicker, Kristina ^a   Fumagalli, Marta ^b   Rosa, Patrizia ^d   Longhi, Luca ^b   Stocchetti, Nino ^b   De Simoni, Maria Grazia ^c   Weber, Marco ^e   Abbracchio, Maria P ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d CNR   (Italy)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Activated microglia; Adult neural precursors; Human brain injury; Lesion repair; Reactive astrocytes

Indexed keywords

GPR17 RECEPTOR; KI 67 ANTIGEN; NESTIN; PURINERGIC P2Y RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOPSY; CELL REGENERATION; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROSURGERY; OLIGODENDROCYTE PRECURSOR CELL; TRAUMATIC BRAIN INJURY;

ADULT; AGED; BRAIN INJURIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NERVE REGENERATION; NEUROGLIA; NEURONS; RECEPTORS, G-PROTEIN-COUPLED; YOUNG ADULT;

EID: 84883460997     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-013-9366-3     Document Type: Article

References (30)

1. Lo EH (2008) A new penumbra: transitioning from injury into repair after stroke. Nature medicine 14(5): 497-500.
2. De Biase LM, Nishiyama A, Bergles DE (2010) Excitability and synaptic communication within the oligodendrocyte lineage. J Neurosci Off J Soc Neurosci 30(10): 3600-3611.
3. Fumagalli M, Lecca D, Abbracchio MP (2011) Role of purinergic signalling in neuro-immune cells and adult neural progenitors. Front Biosci 16: 2326-2341.
4. Simon C, Gotz M, Dimou L (2011) Progenitors in the adult cerebral cortex: cell cycle properties and regulation by physiological stimuli and injury. Glia 59(6): 869-881.
5. Buffo A, Vosko MR, Erturk D, Hamann GF, Jucker M, Rowitch D, Gotz M (2005) Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair. Proc Natl Acad Sci U S A 102(50): 18183-18188.
6. Buffo A, Rite I, Tripathi P, Lepier A, Colak D, Horn AP, Mori T, Gotz M (2008) Origin and progeny of reactive gliosis: a source of multipotent cells in the injured brain. Proc Natl Acad Sci U S A 105(9): 3581-3586.
7. Berninger B, Costa MR, Koch U, Schroeder T, Sutor B, Grothe B, Gotz M (2007) Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia. J Neurosci Off J Soc Neurosci 27(32): 8654-8664.
8. Heinrich C, Gascon S, Masserdotti G, Lepier A, Sanchez R, Simon-Ebert T, Schroeder T, Gotz M, Berninger B (2011) Generation of subtype-specific neurons from postnatal astroglia of the mouse cerebral cortex. Nat Protoc 6(2): 214-228.
9. Richardson WD, Young KM, Tripathi RB, McKenzie I (2011) NG2-glia as multipotent neural stem cells: fact or fantasy? Neuron 70(4): 661-673.
10. Kondo T, Raff M (2000) Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289(5485): 1754-1757.
11. Marchetti B, Abbracchio MP (2005) To be or not to be (inflamed)-is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? Trends Pharmacol Sci 26(10): 517-525.
12. Lecca D, Trincavelli ML, Gelosa P, Sironi L, Ciana P, Fumagalli M, Villa G, Verderio C, Grumelli C, Guerrini U, Tremoli E, Rosa P, Cuboni S, Martini C, Buffo A, Cimino M, Abbracchio MP (2008) The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS One 3(10): e3579.
13. Pugliese AM, Trincavelli ML, Lecca D, Coppi E, Fumagalli M, Ferrario S, Failli P, Daniele S, Martini C, Pedata F, Abbracchio MP (2009) Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTPgammaS binding and electrophysiological studies in 1321N1 cells. Am J Physiol Cell Physiol 297(4): C1028-1040.
14. Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V, Gelosa P, Guerrini U, Belcredito S, Cimino M, Sironi L, Tremoli E, Rovati GE, Martini C, Abbracchio MP (2006) The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 25(19): 4615-4627.
15. Daniele S, Lecca D, Trincavelli ML, Ciampi O, Abbracchio MP, Martini C (2010) Regulation of PC12 cell survival and differentiation by the new P2Y-like receptor GPR17. Cell Signal 22(4): 697-706.
16. Daniele S, Trincavelli ML, Gabelloni P, Lecca D, Rosa P, Abbracchio MP, Martini C (2011) Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands. J Pharmacol Exp Ther 338(2): 559-567.
17. Benned-Jensen T, Rosenkilde MM (2010) Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants. Br J Pharmacol 159(5): 1092-1105.
18. Buccioni M, Marucci G, Dal Ben D, Giacobbe D, Lambertucci C, Soverchia L, Thomas A, Volpini R, Cristalli G (2011) Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17. Purinergic Signal 7(4): 463-468.
19. Maekawa A, Balestrieri B, Austen KF, Kanaoka Y (2009) GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4. Proc Natl Acad Sci U S A 106(28): 11685-11690.
20. Wunder F, Tinel H, Kast R, Geerts A, Becker EM, Kolkhof P, Hutter J, Erguden J, Harter M (2010) Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor. Br J Pharmacol 160(2): 399-409.
21. Back M, Dahlen SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE (2011) International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions. Pharmacol Rev 63(3): 539-584.
22. Eberini I, Daniele S, Parravicini C, Sensi C, Trincavelli ML, Martini C, Abbracchio MP (2011) In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases. J Comput Aided Mol Des 25(8): 743-752.
23. Fumagalli M, Daniele S, Lecca D, Lee PR, Parravicini C, Fields RD, Rosa P, Antonucci F, Verderio C, Trincavelli ML, Bramanti P, Martini C, Abbracchio MP (2011) Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation. J Biol Chem 286(12): 10593-10604.
24. Boda E, Vigano F, Rosa P, Fumagalli M, Labat-Gest V, Tempia F, Abbracchio MP, Dimou L, Buffo A (2011) The GPR17 receptor in NG2 expressing cells: focus on in vivo cell maturation and participation in acute trauma and chronic damage. Glia 59(12): 1958-1973.
25. Ceruti S, Villa G, Genovese T, Mazzon E, Longhi R, Rosa P, Bramanti P, Cuzzocrea S, Abbracchio MP (2009) The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury. Brain 132(Pt 8): 2206-2218.
26. Yu GL, Wei EQ, Zhang SH, Xu HM, Chu LS, Zhang WP, Zhang Q, Chen Z, Mei RH, Zhao MH (2005) Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. Pharmacology 73(1): 31-40.
27. Zanier ER, Ortolano F, Ghisoni L, Colombo A, Losappio S, Stocchetti N (2007) Intracranial pressure monitoring in intensive care: clinical advantages of a computerized system over manual recording. Crit Care 11(1): R7.
28. Boda E, Buffo A (2010) Glial cells in non-germinal territories: insights into their stem/progenitor properties in the intact and injured nervous tissue. Arch Ital Biol 148(2): 119-136.
29. Raff MC (1989) Glial cell diversification in the rat optic nerve. Science 243(4897): 1450-1455.
30. Lecca D, Ceruti S (2008) Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation. Biochem Pharmacol 75(10): 1869-1881.